title: Lack of efficacy of liposomal glucantime in the treatment of cutaneous leishmaniasis.
authors.forename: Vahid Mashayehki
authors.initials: VM
authors.lastname: Ghoyonlo
authors.forename: Mahmoud Reza
authors.initials: MR
authors.lastname: Jafari
authors.forename: Mohammad Javad
authors.initials: MJ
authors.lastname: Yazdanpanah
authors.forename: Habiballah
authors.initials: H
authors.lastname: Esmaili
authors.forename: Soleiman
authors.initials: S
authors.lastname: Noori
authors.affiliation: Cutaneous Leishmaniasis Research Center, Department of Dermatology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
authors.forename: Bita
authors.initials: B
authors.lastname: Kiafar
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D004339:Drug Compounding; D005260:Female; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy*; D008081:Liposomes; D008297:Male; D008536:Meglumine / Q000008:administration & dosage*; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage*; D010865:Pilot Projects; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000981:Antiprotozoal Agents; D008081:Liposomes; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate